首页> 外文OA文献 >The Emerging Role of Myeloid-Derived Suppressor Cells in the Glioma Immune Suppressive Microenvironment
【2h】

The Emerging Role of Myeloid-Derived Suppressor Cells in the Glioma Immune Suppressive Microenvironment

机译:粘粒瘤免疫抑制微环境中粘粒源性抑制细胞的新兴作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Myeloid-derived suppressor cells (MDSCs) are a heterogeneous group of myeloid progenitor and precursor cells at different stages of differentiation, which play an important role in tumor immunosuppression. Glioma is the most common and deadliest primary malignant tumor of the brain, and ample evidence supports key contributions of MDSCs to the immunosuppressive tumor microenvironment, which is a key factor stimulating glioma progression. In this review, we summarize the source and characterization of MDSCs, discuss their immunosuppressive functions, and current approaches that target MDSCs for tumor control. Overall, the review provides insights into the roles of MDSC immunosuppression in the glioma microenvironment and suggests that MDSC control is a powerful cellular therapeutic target for currently incurable glioma tumors.
机译:肌骨衍生的抑制细胞(MDSC)是不同阶段的异质髓样祖细胞和前体细胞,在不同的分化阶段,这在肿瘤免疫抑制中起重要作用。胶质瘤是大脑中最常见和最致命的主要恶性肿瘤,充足的证据支持MDSC对免疫抑制肿瘤微环境的关键贡献,这是刺激胶质瘤进展的关键因素。在本综述中,我们总结了MDSC的来源和表征,讨论其免疫抑制功能,以及靶向肿瘤控制的目前方法。总体而言,审查提供了对MDSC免疫抑制在胶质瘤微环境中的作用的见解,并表明MDSC控制是目前可治愈的胶质瘤肿瘤的强烈细胞治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号